Nephrocare Health Services Ltd share price inched up 0.14% to Rs 624.85 after the company's net profit saw a mild growth of 4.88% to Rs 33.53 crore, while revenue from operations slightly gained 7.68% to Rs 303.4 crore in Q3FY26 over Q2FY26.

The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 82461.7 crore, heading higher 11.61%. It has improved by 0.55% over last one week and edged lower by 2% in last one month while the market capitalization of Nephrocare Health Services Ltd has eased by 0.50% and 9.44% in the same period respectively.

Profit before tax (PBT) of Nephrocare Health Services Ltd stood at Rs 40.41 crore in Q3 FY26, crashing by 6617.74% year-on-year, and slipping 1.51% quarter-on-quarter. EBITDA came in at Rs 59 crore, declining 1.53% YoY and easing 4.79% sequentially.

Total expenses saw a slight increase of 8.89% to Rs 263.96 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 66.25 crore, posting a minor increase of 6.10% YoY, while employee benefits expense was at Rs 52.87 crore, improving by 10.54% YoY.

For the TTM ended FY26, revenue from operations surged 32.16% to Rs 998.85 crore, while net profit expanded by 14.52% to Rs 76.84 crore, compared to previous TTM. EBITDA soared by 16974% to Rs 202.46 crore, and PBT registered a growth of 11.47% to Rs 97.47 crore compared to previous TTM.

The company's consolidated net cash flow from operating activities stood at Rs 232.58 crore in FY26, as against Rs 135.35 crore in FY25.

Nephrocare Health Services Ltd jumped 32.50% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 8.41% during the same period.